577 related articles for article (PubMed ID: 2562699)
21. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis.
Cambridge G; Leandro MJ; Edwards JC; Ehrenstein MR; Salden M; Bodman-Smith M; Webster AD
Arthritis Rheum; 2003 Aug; 48(8):2146-54. PubMed ID: 12905467
[TBL] [Abstract][Full Text] [Related]
22. IgG-, IgM- and IgA-rheumatoid factors in healthy adults and rheumatoid patients determined by an indirect immunofluorescence method.
Kallerup HE; Egeskjold EM; Graudal H
Scand J Rheumatol; 1979; 8(1):1-9. PubMed ID: 373087
[TBL] [Abstract][Full Text] [Related]
23. 7S IgG rheumatoid factor and hidden 19S IgM rheumatoid factor in juvenile chronic arthritis.
Roizenblatt S; Goldenberg J; Gabriel A; Hilário MO; Atra E
Allergol Immunopathol (Madr); 1993; 21(5):197-200. PubMed ID: 8160565
[TBL] [Abstract][Full Text] [Related]
24. Class specific rheumatoid factors in rheumatoid arthritis: response to chrysotherapy and relationship to disease activity.
Rudge SR; Pound JD; Bossingham DH; Powell RJ
J Rheumatol; 1985 Jun; 12(3):432-6. PubMed ID: 3930719
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.
Vallbracht I; Rieber J; Oppermann M; Förger F; Siebert U; Helmke K
Ann Rheum Dis; 2004 Sep; 63(9):1079-84. PubMed ID: 15308516
[TBL] [Abstract][Full Text] [Related]
26. Rheumatoid factor isotypes in localized scleroderma.
Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Tamaki K
Clin Exp Dermatol; 2005 Jul; 30(4):405-8. PubMed ID: 15953082
[TBL] [Abstract][Full Text] [Related]
27. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
Rantapää-Dahlqvist S; de Jong BA; Berglin E; Hallmans G; Wadell G; Stenlund H; Sundin U; van Venrooij WJ
Arthritis Rheum; 2003 Oct; 48(10):2741-9. PubMed ID: 14558078
[TBL] [Abstract][Full Text] [Related]
28. [Value of anti-cyclic citrullinated peptides antibodies in comparison with rheumatoid factor for rheumatoid arthritis diagnosis].
Dubrous P; Gardet V; Hugard L
Pathol Biol (Paris); 2005 Mar; 53(2):63-7. PubMed ID: 15708648
[TBL] [Abstract][Full Text] [Related]
29. [Rheumatoid factor in rheumatoid arthritis in old age].
Vencovský J
Cas Lek Cesk; 1991 Jan; 130(4):108-11. PubMed ID: 2004398
[TBL] [Abstract][Full Text] [Related]
30. Quantitation of rheumatoid factors (RF) of IgM, IgA and IgG isotypes by a simple and sensitive ELISA. Discrimination between false and true IgG-RF.
Kleveland G; Egeland T; Lea T
Scand J Rheumatol Suppl; 1988; 75():15-24. PubMed ID: 3070722
[TBL] [Abstract][Full Text] [Related]
31. Detection of rheumatoid factors of different isotypes and of circulating immune complexes in patients with inflammatory bowel disease.
Procaccia S; Bianchi Porro G; Colucci A; Villa P; Blasio R; Ardizzone S; Bonacina CA; Zanussi C
Boll Ist Sieroter Milan; 1990 Jun; 69(2):413-21. PubMed ID: 2152301
[TBL] [Abstract][Full Text] [Related]
32. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.
Nikolaisen C; Rekvig OP; Nossent HC
Scand J Rheumatol; 2005; 34(4):269-76. PubMed ID: 16195159
[TBL] [Abstract][Full Text] [Related]
33. [High levels of blood IgA in patients with rheumatoid arthritis].
Ferlazzo B; Bonanno D; Quattrocchi P; Mazzeo L; Barrile A
Minerva Med; 1997; 88(7-8):283-7. PubMed ID: 9304070
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of rheumatoid test procedures--value and critical interpretation of sensitivity and specificity and their effect on pre-test and post-test probability].
Aupperle KR; Alsalameh S; Stock KP; Burmester GR; Kalden JR
Z Rheumatol; 1996; 55(3):158-67. PubMed ID: 8768145
[TBL] [Abstract][Full Text] [Related]
35. [Serum immunoglobulin patterns in rheumatoid arthritis].
Dreher R
Z Rheumatol; 1977; 36(1-2):3-21. PubMed ID: 842145
[TBL] [Abstract][Full Text] [Related]
36. [Rheumatoid factors. Isotypes and severity of rheumatoid polyarthritis].
Fouquet B; Renoux M; Eveleich MC; Bardos P; Valat JP
Rev Rhum Mal Osteoartic; 1987 Jan; 54(1):31-5. PubMed ID: 3563364
[TBL] [Abstract][Full Text] [Related]
37. Blockade of tumour necrosis factor {alpha} significantly alters the serum level of IgG- and IgA-rheumatoid factor in patients with rheumatoid arthritis.
Yazdani-Biuki B; Stadlmaier E; Mulabecirovic A; Brezinschek R; Tilz G; Demel U; Mueller T; Brickmann K; Graninger WB; Brezinschek HP
Ann Rheum Dis; 2005 Aug; 64(8):1224-6. PubMed ID: 16014683
[TBL] [Abstract][Full Text] [Related]
38. IgG rheumatoid factors against the four human Fc-gamma subclasses in early rheumatoid arthritis (the Swedish TIRA project).
Kanmert D; Kastbom A; Almroth G; Skogh T; Enander K; Wetterö J
Scand J Immunol; 2012 Jan; 75(1):115-9. PubMed ID: 21916920
[TBL] [Abstract][Full Text] [Related]
39. Relationship of soluble interleukin-2-receptor and interleukin-6 with class-specific rheumatoid factors during low-dose methotrexate treatment in rheumatoid arthritis.
Spadaro A; Taccari E; Riccieri V; Sensi F; Sili Scavalli A; Zoppini A
Rev Rhum Engl Ed; 1997 Feb; 64(2):89-94. PubMed ID: 9085442
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of IgA rheumatoid factor subclasses in rheumatoid arthritis.
Houssien DA; Jonsson T; Davies E; Scott DL
J Rheumatol; 1997 Nov; 24(11):2119-22. PubMed ID: 9375869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
